LONDON — U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K. The weight-loss treatment firm and creator of Zepbound announced Monday that it would commit £279 million ($364 million) to help tackle Britain’s significant health challenges — including obesity. … Read more
Britain’s Prime Minister Keir Starmer delivers a speech on stage during the International Investment Summit, held at The Guildhall, in central London, on October 14, 2024. Jonathan Brady | Afp | Getty Images LONDON — The U.K.’s Labour government said Monday that it had secured £63 billion ($82 billion) in fresh investment at the close … Read more
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg told CNBC Thursday that early-stage trials of its experimental obesity injection point to higher-quality weight loss — with reduced muscle loss and fewer side effects — … Read more
